An open label, balanced, randomized clinical trial to evaluate safety & efficacy of piperine 225 mg with standard anti tubercular treatment in newly diagnosed sputum positive drug sensitive pulmonary TB adult patients in comparison with standard ..
Implementing Organization
National Institute of Tuberculosis & Respiratory Diseases, Delhi
Principal Investigator
Mr. R. Sarin
Director
|
National Institute of Tuberculosis & Respiratory Diseases, Delhi